TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea · Delayed Price · Currency is KRW 1,992.00
-33.00 (-1.63%)
Oct 30, 2026, 3:30 PM KST
TELCON RF PHARMACEUTICAL. Market Cap
TELCON RF PHARMACEUTICAL. has a market cap or net worth of 11.2 billion as of October 30, 2026. It is the 42,386th most valuable company in the world and the 2,606th biggest in South Korea. Its market cap has decreased by 72.31% in one year.
Market Cap
11.20B
Enterprise Value
63.91B
Revenue
61.78B
Global Rank
Country Rank
#2,606 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 24, 2014, TELCON RF PHARMACEUTICAL.'s market cap has decreased from 59.01B to 11.20B, a decrease of -81.02%. That is a compound annual growth rate of -12.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 11.20B | -82.18% |
| Dec 30, 2025 | 62.83B | -10.99% |
| Dec 30, 2024 | 70.59B | -27.73% |
| Dec 28, 2023 | 97.67B | -11.39% |
| Dec 29, 2022 | 110.23B | -56.93% |
| Dec 30, 2021 | 255.96B | -50.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dong Sung Bio Pharm.Co.,Ltd. | 112.29B |
| HANDOK | 106.66B |
| Jeil Pharma Holdings | 103.16B |
| Enzychem Lifesciences | 76.86B |
| Kukje Pharma | 70.78B |
| CKD Bio | 67.64B |
| Ildong Holdings | 65.32B |
| CMG Pharmaceutical | 61.77B |